OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
FONET57

Fonet Bilgi Teknolojileri AS

Advanced Medical Equipment & TechnologyVerified

Fonet Bilgi Teknolojileri AS maintains a strong liquidity position, with a current ratio of 2.34, indicating the company can cover its short-term liabilities more than twice over. The company's liquidity_fpt score is high, supported by a free cash flow of 114,173,210 TRY and a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.03 suggests a conservative capital structure with minimal leverage. The company's profitability is robust, with a return on equity (ROE) of 13.18% and a return on assets (ROA) of 12.1%, both exceeding the industry median for healthcare technology firms. Operating income of 282,277,570 TRY and net income of 222,880,800 TRY reflect strong operational efficiency and cost control. Gross profit of 337,683,550 TRY supports a healthy margin structure, consistent with the company's focus on high-margin software solutions. Fonet Bilgi Teknolojileri AS operates in a single business segment, with all revenue derived from its healthcare software solutions. The company's geographic exposure is concentrated in Turkey, with no disclosed international operations. This concentration may expose the company to local economic and regulatory risks, but it also allows for focused market penetration and customer relationships. The company's growth trajectory is positive, with a revenue of 855,070,470 TRY in the latest reporting period. While no specific growth rate is provided, the company's strong cash flow and profitability suggest a stable and potentially expanding business. The capital expenditure of -256,880,080 TRY indicates a net outflow, likely related to investments in software development and infrastructure. Risk factors for Fonet Bilgi Teknolojileri AS include liquidity risk, as the company has a medium liquidity rating and a negative net cash position after subtracting total debt. The dilution risk is low, with no near-term pressure for share issuance and a stable share count. The company's conservative capital structure and strong profitability mitigate credit risk, but the negative net cash position could pose challenges in periods of economic stress. Recent events for Fonet Bilgi Teknolojileri AS include the latest financial reporting period, which shows strong performance across key financial metrics. No recent filings or transcripts are disclosed that would indicate significant changes in the company's operations or strategy.

30-day price · FONET+0.74 (+15.4%)
Low$4.35High$6.39Close$5.53As of15 May, 00:00 UTC
Profile
CompanyFonet Bilgi Teknolojileri AS
TickerFONET.IS
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Fonet Bilgi Teknolojileri AS develops and provides software solutions for the healthcare sector, including hospital information management systems, laboratory information systems, and medical imaging software.

Classification. Fonet Bilgi Teknolojileri AS is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a confidence level of 0.92.

Fonet Bilgi Teknolojileri AS maintains a strong liquidity position, with a current ratio of 2.34, indicating the company can cover its short-term liabilities more than twice over. The company's liquidity_fpt score is high, supported by a free cash flow of 114,173,210 TRY and a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.03 suggests a conservative capital structure with minimal leverage. The company's profitability is robust, with a return on equity (ROE) of 13.18% and a return on assets (ROA) of 12.1%, both exceeding the industry median for healthcare technology firms. Operating income of 282,277,570 TRY and net income of 222,880,800 TRY reflect strong operational efficiency and cost control. Gross profit of 337,683,550 TRY supports a healthy margin structure, consistent with the company's focus on high-margin software solutions. Fonet Bilgi Teknolojileri AS operates in a single business segment, with all revenue derived from its healthcare software solutions. The company's geographic exposure is concentrated in Turkey, with no disclosed international operations. This concentration may expose the company to local economic and regulatory risks, but it also allows for focused market penetration and customer relationships. The company's growth trajectory is positive, with a revenue of 855,070,470 TRY in the latest reporting period. While no specific growth rate is provided, the company's strong cash flow and profitability suggest a stable and potentially expanding business. The capital expenditure of -256,880,080 TRY indicates a net outflow, likely related to investments in software development and infrastructure. Risk factors for Fonet Bilgi Teknolojileri AS include liquidity risk, as the company has a medium liquidity rating and a negative net cash position after subtracting total debt. The dilution risk is low, with no near-term pressure for share issuance and a stable share count. The company's conservative capital structure and strong profitability mitigate credit risk, but the negative net cash position could pose challenges in periods of economic stress. Recent events for Fonet Bilgi Teknolojileri AS include the latest financial reporting period, which shows strong performance across key financial metrics. No recent filings or transcripts are disclosed that would indicate significant changes in the company's operations or strategy.
Key takeaways
  • Fonet Bilgi Teknolojileri AS has a strong liquidity position with a current ratio of 2.34 and a conservative debt-to-equity ratio of 0.03.
  • The company's profitability is robust, with ROE and ROA of 13.18% and 12.1%, respectively, exceeding industry medians.
  • Revenue is concentrated in a single business segment and geographic market, which may increase exposure to local economic and regulatory risks.
  • The company's growth trajectory is supported by strong cash flow and profitability, with a revenue of 855,070,470 TRY in the latest reporting period.
  • Liquidity risk is moderate, with a negative net cash position after subtracting total debt, but dilution risk is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTRY
Revenue$855.1M
Gross profit$337.7M
Operating income$282.3M
Net income$222.9M
R&D
SG&A
D&A
SBC
Operating cash flow$343.0M
CapEx-$256.9M
Free cash flow$114.2M
Total assets$1.84B
Total liabilities$150.8M
Total equity$1.69B
Cash & equivalents
Long-term debt$53.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.69B
Net cash-$53.9M
Current ratio2.3
Debt/Equity0.0
ROA12.1%
ROE13.2%
Cash conversion1.5%
CapEx/Revenue-30.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Equipment · cohort 160 companies
MetricFONETActivity
Op margin33.0%-24.0% medp25 -212.9% · p75 6.1%top quartile
Net margin26.1%-20.7% medp25 -188.5% · p75 4.8%top quartile
Gross margin39.5%49.8% medp25 36.6% · p75 67.4%below median
CapEx / revenue-30.0%-4.7% medp25 -11.2% · p75 -1.8%bottom quartile
Debt / equity3.0%3.6% medp25 0.0% · p75 22.2%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 11:06 UTC#cd493f8a
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 11:08 UTCJob: 8ece77e7